Sarepta shares leap on FDA’s eteplirsen overview delay
stocks of Sarepta Therapeutics rose nearly 27 percent Wednesday after announcing the meals and Drugadministration is delaying its evaluate of ...
Tag: Sarepta
Sarepta inventory nuked by FDA outlook
res of Sarepta Therapeutics nearly halved on Thursday after the meals and Drug management maintained its "poor" outlook on the ...